Article
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study.
Molecular neurodegeneration - 27 Nov 2021
Bergström Sofia, Öijerstedt Linn, Remnestål Julia, Olofsson Jennie, Ullgren Abbe, Seelaar Harro, van Swieten John C, Synofzik Matthis, Sanchez-Valle Raquel, Moreno Fermin, Finger Elizabeth, Masellis Mario, Tartaglia Carmela, Vandenberghe Rik, Laforce Robert, Galimberti Daniela, Borroni Barbara, Butler Chris R, Gerhard Alexander, Ducharme Simon, Rohrer Jonathan D, Månberg Anna, Graff Caroline, Nilsson Peter
Abstract excerpt
BACKGROUND: A detailed understanding of the pathological processes involved in genetic frontotemporal dementia is critical in order to provide the patients with an optimal future treatment. Protein levels in CSF have the potential to reflect different pathophysiological processes in the brain. We aimed to identify and evaluate panels of CSF proteins with potential to separate symptomatic individuals from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
